MedImmune Takes Back FluMist: Physician Education, Not DTC, Will Be Near-Term Focus
This article was originally published in The Pink Sheet Daily
Executive Summary
MedImmune will add 55 commercial positions to help compensate for the loss of the Wyeth partnership. MedImmune will pay Wyeth $25 mil. plus future royalties and milestones under dissolution agreement.